Ron Hoffman Selected Research

Ron Hoffman Research Topics

Disease

4	Hemorrhage 01/2009 - 01/2004
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019 - 10/2005
3	Hematologic Neoplasms (Hematological Malignancy) 09/2016 - 06/2004
2	Mental Disorders (Mental Disorder) 07/2022 - 01/2019
2	Leukemia 11/2019 - 11/2005
2	Infections 03/2019 - 09/2016
2	Thrombocytopenia (Thrombopenia) 03/2019 - 10/2005
2	Venous Thromboembolism 10/2018 - 06/2004
2	Neoplasms (Cancer) 01/2016 - 12/2006
2	Body Weight (Weight, Body) 10/2005 - 01/2004
2	Thrombosis (Thrombus) 01/2005 - 06/2004
2	Activated Protein C Resistance (APC Resistance) 07/2002 - 02/2002
1	Syncope (Fainting) 03/2022
1	Pulmonary Embolism 03/2022
1	Hemophilia A (Haemophilia) 03/2019
1	Glioma (Gliomas) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2016
1	Thromboembolism 09/2012
1	Chronic Renal Insufficiency 10/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2005
1	Ischemic Stroke 10/2005
1	Aplastic Anemia (Anemia, Hypoplastic) 10/2005
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2005
1	Hodgkin Disease (Hodgkin's Disease) 10/2005
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2005
1	Acute Promyelocytic Leukemia 01/2005
1	Thrombotic Microangiopathies 06/2004
1	Central Nervous System Diseases (CNS Diseases) 01/2003
1	Primary Myelofibrosis (Myelosclerosis) 03/2002
1	Antithrombin III Deficiency 02/2002
1	Thrombophilia 02/2002

Drug/Important Bio-Agent (IBA)

4	AnticoagulantsIBA 10/2011 - 01/2004
3	fibrin fragment D (D-dimer)IBA 03/2022 - 01/2004
3	Protein CIBA 12/2006 - 02/2002
2	Hemostatics (Antihemorrhagics)IBA 10/2018 - 01/2005
2	factor V LeidenIBA 07/2002 - 02/2002
2	Protein SIBA 07/2002 - 02/2002
1	Indicators and Reagents (Reagents)IBA 07/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2019
1	ProdrugsIBA 11/2019
1	Heparin (Liquaemin)FDA LinkGeneric 03/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2019
1	AntibodiesIBA 03/2019
1	SteroidsIBA 03/2019
1	Rituximab (Mabthera)FDA Link 03/2019
1	Platelet Activating FactorIBA 03/2019
1	Biological ProductsIBA 01/2019
1	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2016
1	heparanaseIBA 01/2016
1	Warfarin (Coumadin)FDA LinkGeneric 09/2012
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 09/2012
1	Thromboplastin (Tissue Factor)IBA 11/2005
1	Urokinase Plasminogen Activator ReceptorsIBA 11/2005
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 11/2005
1	ThrombomodulinIBA 11/2005
1	PAR-1 ReceptorIBA 11/2005
1	recombinant FVIIa (rFVIIa)FDA Link 10/2005
1	Factor VIIa (Activated Factor VII)IBA 10/2005
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2004
1	Cisplatin (Platino)FDA LinkGeneric 06/2004
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2004
1	Thalidomide (Thalomid)FDA Link 06/2004
1	Pharmaceutical PreparationsIBA 06/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2004
1	Gemcitabine FDA Link 06/2004
1	Detergents (Detergent)IBA 01/2004
1	prothrombin complex concentrates (PPSB)IBA 01/2004
1	SolventsIBA 01/2004
1	Prothrombin (Factor II)IBA 02/2002
1	Antiphospholipid AntibodiesIBA 02/2002

Therapy/Procedure

5	Therapeutics 11/2019 - 03/2002
2	Transplantation 01/2003 - 03/2002
1	Immunomodulation 03/2019
1	Combination Drug Therapy (Combination Chemotherapy) 06/2004
1	Anticoagulation Reversal 01/2004